H. Rainer

429 total citations
40 papers, 321 citations indexed

About

H. Rainer is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, H. Rainer has authored 40 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in H. Rainer's work include Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and T-cell and Retrovirus Studies (3 papers). H. Rainer is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and T-cell and Retrovirus Studies (3 papers). H. Rainer collaborates with scholars based in Austria, Germany and United Kingdom. H. Rainer's co-authors include R. Jakesz, W. Weidner, M. Ludwig, T. Diemer, P. Huwe, M. Schemper, D. Giesecke, G. Steger, Keith Moser and Robert M. Mader and has published in prestigious journals such as The Lancet, Annals of Surgery and Annals of the New York Academy of Sciences.

In The Last Decade

H. Rainer

36 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Rainer Austria 10 119 78 76 42 41 40 321
N W Derias United Kingdom 12 113 0.9× 124 1.6× 68 0.9× 77 1.8× 13 0.3× 22 413
T Tallberg Finland 11 62 0.5× 78 1.0× 88 1.2× 53 1.3× 15 0.4× 36 307
A Burkhardt Germany 12 73 0.6× 65 0.8× 95 1.3× 75 1.8× 26 0.6× 44 420
Nakamura Rm Japan 8 65 0.5× 60 0.8× 58 0.8× 106 2.5× 41 1.0× 26 372
S. Stefanaki Greece 13 90 0.8× 130 1.7× 36 0.5× 116 2.8× 17 0.4× 25 383
Catalona Wj United States 8 91 0.8× 330 4.2× 111 1.5× 87 2.1× 42 1.0× 23 466
P. Moerman Belgium 13 68 0.6× 64 0.8× 211 2.8× 131 3.1× 19 0.5× 27 563
Roy Baynes South Africa 13 145 1.2× 43 0.6× 45 0.6× 107 2.5× 17 0.4× 20 604
Toshiki Tanikawa Japan 10 107 0.9× 160 2.1× 76 1.0× 105 2.5× 19 0.5× 39 349
Pickren Jw 8 158 1.3× 101 1.3× 99 1.3× 36 0.9× 7 0.2× 17 343

Countries citing papers authored by H. Rainer

Since Specialization
Citations

This map shows the geographic impact of H. Rainer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Rainer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Rainer more than expected).

Fields of papers citing papers by H. Rainer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Rainer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Rainer. The network helps show where H. Rainer may publish in the future.

Co-authorship network of co-authors of H. Rainer

This figure shows the co-authorship network connecting the top 25 collaborators of H. Rainer. A scholar is included among the top collaborators of H. Rainer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Rainer. H. Rainer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weidner, W., T. Diemer, P. Huwe, H. Rainer, & M. Ludwig. (2002). The role of Chlamydia trachomatis in prostatitis. International Journal of Antimicrobial Agents. 19(6). 466–470. 59 indexed citations
2.
Mader, Robert M., W. Millesi, Stephan Lang, et al.. (1996). First‐pass uptake of methotrexate after intra‐arterial bolus injection in human head and neck cancers. European Journal of Clinical Investigation. 26(5). 371–375. 1 indexed citations
3.
Heys, S, Oleg Eremin, Enzo Maria Ruggeri, et al.. (1995). A phase III study of recombinant interleukin-2, 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal carcinoma. European Journal of Cancer. 31(1). 19–25. 12 indexed citations
4.
Mader, Robert M., et al.. (1994). Comparison of an Immunoradiometric and an Immunoluminometric Assay for the Evaluation of the Tumour Associated Antigens CA 19-9 and CA 125. Clinical Chemistry and Laboratory Medicine (CCLM). 32(2). 85–90. 1 indexed citations
5.
Stühlinger, Markus, et al.. (1994). Clinical therapy and HER-2 oncogene amplification in breast cancer: Chemo- vs radiotherapy. The Journal of Steroid Biochemistry and Molecular Biology. 49(1). 39–42. 3 indexed citations
6.
Ulsperger, Ernst, H. Rainer, Gershon Y. Locker, et al.. (1993). Adjuvant Vaccination in Colorectal Carcinoma. Annals of the New York Academy of Sciences. 690(1). 360–363. 2 indexed citations
7.
Steger, G., et al.. (1991). Complete remission of metastasisted clear cell sarcoma of tendons and aponeuroses. European Journal of Cancer. 27(3). 254–256. 20 indexed citations
8.
Rainer, H., et al.. (1991). Purin- und Pyrimidinmetaboliten zur Beurteilung des Pansenstoffwechsels: HPLC-Analysen in Milch und Blutplasma. Archiv für Tierernaehrung. 41(4). 411–426. 30 indexed citations
9.
Jakesz, R., G. Reiner, M. Schemper, et al.. (1989). Significant Survival Benefit of Node-Negative Breast Cancer Patients Treated with Adjuvant Chemotherapy: Seven-year Results. Recent results in cancer research. 115. 180–185. 3 indexed citations
10.
Eichler, H G, H. Rainer, R. Jakesz, et al.. (1988). Escalating dose regimen of intraperitoneal mitoxantrone: Phase I study—clinical and pharmacokinetic evaluation. European Journal of Cancer and Clinical Oncology. 24(7). 1133–1138. 21 indexed citations
11.
Jakesz, R., C. Dittrich, Martin Funovics, et al.. (1988). The Effect of Adjuvant Chemotherapy in Gastric Carcinoma Is Dependent on Tumor Histology: 5- Year Results of a Prospective Randomized Trial. Recent results in cancer research. 110. 44–51. 25 indexed citations
12.
Eichler, H.-G., H. Rainer, R. Jakesz, et al.. (1987). Phase-I Study of Intraperitoneal Mitoxantrone – Clinical and Pharmacokinetic Evaluation. Oncology Research and Treatment. 10(1). 54–56. 7 indexed citations
13.
Wunderlich, M, R Schiessel, H. Rainer, et al.. (1985). Effect of adjuvant chemo- or immunotherapy on the prognosis of colorectal cancer operated for cure. British journal of surgery. 72(Supplement_1). s107–s110. 14 indexed citations
14.
Micksche, M., et al.. (1982). Plasmapheresis in Patients with Advanced Malignant Disease: A Pilot Study. Oncology. 39(3). 146–151. 9 indexed citations
15.
Francesconi, Mirko, et al.. (1982). The value of prognostic parameters for the stratification of advanced breast cancer patients. Journal of Cancer Research and Clinical Oncology. 102(3). 289–299. 5 indexed citations
16.
Rainer, H. & R. Maschler. (1979). The Influence of Spermine, Spermidine and Various Sera on T-Lymphocyte and Granulocyte Colony Growth in vitro. Zeitschrift für Naturforschung C. 34(5-6). 452–459. 7 indexed citations
17.
Rainer, H., Keith Moser, & Peter Bettelheim. (1978). [Randomized study: chemotherapy versus chemotherapy plus transfer factor in metastasized breast neoplasm].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 604–6. 1 indexed citations
18.
19.
Rainer, H.. (1974). Gibt es Zusammenh�nge zwischen Erdbeben und Gebirgsschlagh�ufungen im Bergbau Bleiberg?. Rock Mechanics and Rock Engineering. 6(2). 91–100. 2 indexed citations
20.
Rainer, H., U. Ganzinger, P Höcker, et al.. (1974). Steigerung der Aufnahme Aminoacylierter Transferribonucleinsäuren menschlicher Leukocyten nach Genaktivierung durch Phytohæmagglutinin und bei Leukämie. Journal of Molecular Medicine. 52(3). 138–142. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N W Derias Breakdown of academic impact, for papers by T Tallberg Breakdown of academic impact, for papers by A Burkhardt Breakdown of academic impact, for papers by Nakamura Rm Breakdown of academic impact, for papers by S. Stefanaki Breakdown of academic impact, for papers by Catalona Wj Breakdown of academic impact, for papers by P. Moerman Breakdown of academic impact, for papers by Roy Baynes Breakdown of academic impact, for papers by Toshiki Tanikawa Breakdown of academic impact, for papers by Pickren Jw
Rankless by CCL
2026